SentinelOne (S) 10-Q 31 Aug 23 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2023	Aug. 25, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	001-40531
Entity Registrant Name	SENTINELONE, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	99-0385461
Entity Address, Address Line One	444 Castro Street, Suite 400
Entity Address, City or Town	Mountain View
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94041
City Area Code	(855)
Local Phone Number	868-3733
Title of 12(b) Security	Class A common stock, par value $0.0001
Trading Symbol	S
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Central Index Key	0001583708
Class A
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		242,179,776
Class B
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		53,494,056

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 133,065	$ 137,941
Short-term investments	598,531	485,584
Accounts receivable, net	124,525	151,492
Deferred contract acquisition costs, current	42,825	37,904
Prepaid expenses and other current assets	95,815	101,812
Total current assets	994,761	914,733
Property and equipment, net	43,878	38,741
Operating lease right-of-use assets	22,015	23,564
Long-term investments	410,307	535,422
Deferred contract acquisition costs, non-current	58,624	55,536
Intangible assets, net	131,127	145,093
Goodwill	540,308	540,308
Other assets	6,177	5,516
Total assets	2,207,197	2,258,913
Current liabilities:
Accounts payable	13,840	11,214
Accrued liabilities	104,483	100,015
Accrued payroll and benefits	50,393	54,955
Operating lease liabilities, current	4,637	3,895
Deferred revenue, current	325,019	303,200
Total current liabilities	498,372	473,279
Deferred revenue, non-current	96,343	103,062
Operating lease liabilities, non-current	20,519	23,079
Other liabilities	2,644	2,788
Total liabilities	617,878	602,208
Commitments and contingencies (Note 9)
Stockholders’ equity:
Additional paid-in capital	2,795,019	2,663,394
Accumulated other comprehensive loss	(8,971)	(6,367)
Accumulated deficit	(1,196,758)	(1,000,351)
Total stockholders’ equity	1,589,319	1,656,705
Total liabilities and stockholders’ equity	2,207,197	2,258,913
Class A
Stockholders’ equity:
Common stock, value, issued	24	21
Class B
Stockholders’ equity:
Common stock, value, issued	$ 5	$ 8

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jul. 31, 2023	Jan. 31, 2023
Class A
Common stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,500,000,000	1,500,000,000
Common stock, shares, issued (in shares)	241,390,522	222,951,206
Common stock, shares, outstanding (in shares)	241,390,522	222,951,206
Class B
Common stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares, issued (in shares)	53,508,084	63,812,651
Common stock, shares, outstanding (in shares)	53,508,084	63,812,651

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Statement [Abstract]
Revenue	$ 149,421	$ 102,505	$ 282,814	$ 180,760
Cost of revenue	44,667	36,261	87,250	63,400
Gross profit	104,754	66,244	195,564	117,360
Operating expenses:
Research and development	54,161	54,989	109,424	100,870
Sales and marketing	98,262	79,000	197,433	139,641
General and administrative	48,433	40,447	100,186	75,337
Restructuring (Note 11)	4,255	0	4,255	0
Total operating expenses	205,111	174,436	411,298	315,848
Loss from operations	(100,357)	(108,192)	(215,734)	(198,488)
Interest income	11,489	3,222	22,024	4,309
Interest expense	(605)	(607)	(1,212)	(612)
Other expense, net	1,409	427	1,050	136
Loss before income taxes	(88,064)	(105,150)	(193,872)	(194,655)
Provision (benefit) for income taxes	1,474	(8,844)	2,535	(8,515)
Net loss	$ (89,538)	$ (96,306)	$ (196,407)	$ (186,140)
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share)	$ (0.31)	$ (0.35)	$ (0.68)	$ (0.68)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share)	$ (0.31)	$ (0.35)	$ (0.68)	$ (0.68)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	293,170,401	277,417,227	290,775,910	273,424,105
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	293,170,401	277,417,227	290,775,910	273,424,105

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (89,538)	$ (96,306)	$ (196,407)	$ (186,140)
Other comprehensive income (loss):
Change in unrealized losses on investments	(3,358)	(1,230)	(2,604)	(2,467)
Total comprehensive loss	$ (92,896)	$ (97,536)	$ (199,011)	$ (188,607)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Class A and Class B Common Stock Class A and Class B Common Stock
Shares, beginning of period (in shares) at Jan. 31, 2022					270,451,615
Balance, beginning of period at Jan. 31, 2022	$ 1,650,788	$ 2,271,980	$ 454	$ (621,673)	$ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					3,369,153
Issuance of common stock upon exercise of stock options	8,381	8,381
Vesting of restricted stock units (in shares)					317,854
Issuance of common stock under employee stock purchase plan (in shares)					405,534
Issuance of common stock under employee stock purchase plan	8,682	8,682
Vesting of early exercised stock options	18	18
Issuance of common stock in connection with acquisition (in shares)					6,032,231
Issuance of common stock in connection with acquisition	186,333	186,332			$ 1
Stock-based compensation	74,221	74,221
Other comprehensive loss	(2,467)		(2,467)
Net loss	(186,140)			(186,140)
Shares, end of period (in shares) at Jul. 31, 2022					280,576,387
Balance, end of period at Jul. 31, 2022	1,739,816	2,549,614	(2,013)	(807,813)	$ 28
Shares, beginning of period (in shares) at Apr. 30, 2022					272,496,624
Balance, beginning of period at Apr. 30, 2022	1,597,242	2,309,505	(783)	(711,507)	$ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					1,350,556
Issuance of common stock upon exercise of stock options	3,291	3,291
Vesting of restricted stock units (in shares)					291,442
Issuance of common stock under employee stock purchase plan (in shares)					405,534
Issuance of common stock under employee stock purchase plan	8,682	8,682
Issuance of common stock in connection with acquisition (in shares)					6,032,231
Issuance of common stock in connection with acquisition	186,333	186,332			$ 1
Stock-based compensation	41,804	41,804
Other comprehensive loss	(1,230)		(1,230)
Net loss	(96,306)			(96,306)
Shares, end of period (in shares) at Jul. 31, 2022					280,576,387
Balance, end of period at Jul. 31, 2022	1,739,816	2,549,614	(2,013)	(807,813)	$ 28
Shares, beginning of period (in shares) at Jan. 31, 2023					286,763,857
Balance, beginning of period at Jan. 31, 2023	1,656,705	2,663,394	(6,367)	(1,000,351)	$ 29
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					5,074,687
Issuance of common stock upon exercise of stock options	13,845	13,845
Vesting of restricted stock units (in shares)					2,491,451
Issuance of common stock under employee stock purchase plan (in shares)					568,611
Issuance of common stock under employee stock purchase plan	6,416	6,416
Vesting of early exercised stock options	169	169
Stock-based compensation	111,195	111,195
Other comprehensive loss	(2,604)		(2,604)
Net loss	(196,407)			(196,407)
Shares, end of period (in shares) at Jul. 31, 2023					294,898,606
Balance, end of period at Jul. 31, 2023	1,589,319	2,795,019	(8,971)	(1,196,758)	$ 29
Shares, beginning of period (in shares) at Apr. 30, 2023					291,225,065
Balance, beginning of period at Apr. 30, 2023	1,617,174	2,729,978	(5,613)	(1,107,220)	$ 29
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					1,372,895
Issuance of common stock upon exercise of stock options	4,083	4,083
Vesting of restricted stock units (in shares)					1,732,035
Issuance of common stock under employee stock purchase plan (in shares)					568,611
Issuance of common stock under employee stock purchase plan	6,416	6,416
Vesting of early exercised stock options	120	120
Stock-based compensation	54,422	54,422
Other comprehensive loss	(3,358)		(3,358)
Net loss	(89,538)			(89,538)
Shares, end of period (in shares) at Jul. 31, 2023					294,898,606
Balance, end of period at Jul. 31, 2023	$ 1,589,319	$ 2,795,019	$ (8,971)	$ (1,196,758)	$ 29

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (196,407)	$ (186,140)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	18,623	10,794
Amortization of deferred contract acquisition costs	22,263	32,532
Non-cash operating lease costs	1,973	1,609
Stock-based compensation expense	108,395	72,631
Loss on investments, accretion of discounts, and amortization of premiums on investments, net	(11,089)	(1,167)
Gain on strategic investments	(2,000)	0
Other	775	(452)
Accounts receivable	27,926	480
Prepaid expenses and other assets	6,291	(9,151)
Deferred contract acquisition costs	(30,272)	(39,287)
Accounts payable	1,044	6,094
Accrued liabilities	4,386	4,148
Accrued payroll and benefits	(4,393)	(23,669)
Operating lease liabilities	(2,434)	(2,737)
Deferred revenue	15,101	31,285
Other liabilities	(144)	(8,447)
Net cash used in operating activities	(39,962)	(111,477)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(494)	(4,101)
Purchases of intangible assets	(213)	(194)
Capitalization of internal-use software	(6,165)	(6,028)
Purchases of investments	(350,416)	(1,243,594)
Sales and maturities of investments	371,996	291,845
Cash paid for acquisition, net of cash and restricted cash acquired	0	(281,032)
Net cash provided by (used in) investing activities	14,708	(1,243,104)
CASH FLOW FROM FINANCING ACTIVITIES:
Payments of deferred offering costs	0	(186)
Proceeds from exercise of stock options	13,845	8,382
Proceeds from issuance of common stock under the employee stock purchase plan	6,416	8,682
Net cash provided by financing activities	20,261	16,878
NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(4,993)	(1,337,703)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–Beginning of period	202,406	1,672,051
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–End of period	197,413	334,348
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Income taxes paid, net of refunds	977	(69)
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock-based compensation capitalized as internal-use software	2,800	1,590
Property and equipment purchased but not yet paid	525	836
Internal-use software capitalized but not yet paid	68	383
Vesting of early exercised stock options	169	18
Issuance of common stock and assumed equity awards in connection with acquisition	$ 0	$ 186,332

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	ORGANIZATION AND DESCRIPTION OF BUSINESSBusinessSentinelOne, Inc. (SentinelOne, we, our, or us) was incorporated in January 2013 in the State of Delaware. We are a cybersecurity provider that delivers an artificial intelligence-powered platform to enable autonomous cybersecurity defense. Our headquarters is located in Mountain View, California with various other global office locations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP), and applicable rules and regulations of the Securities and Exchange Commission (SEC), regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023 filed with the SEC on March 29, 2023 (Annual Report). In management’s opinion, the accompanying unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which reflect all normal recurring adjustments necessary to present fairly the results for the interim periods, but are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. Principles of Consolidation The condensed consolidated financial statements include the accounts of SentinelOne and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our condensed consolidated financial statements. There have been no material changes in our use of estimates during the six months ended July 31, 2023, as compared to the use of estimates disclosed in our Annual Report. Significant Accounting Policies There have been no material changes to our significant accounting policies as compared to the significant accounting policies described in our Annual Report. Segment and Geographic Information We have a single operating and reportable segment. Our chief operating decision maker (CODM) is our Chief Executive Officer. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and assessing financial performance. For information regarding our revenue by geography, see Note 3. Cash, Cash Equivalents, and Restricted Cash The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the condensed consolidated statements of cash flows (in thousands): As of July 31, As of January 31, 2023 2023 Cash and cash equivalents $ 133,065 $ 137,941 Restricted cash, current 61,264 61,264 Restricted cash, non-current 3,084 3,201 $ 197,413 $ 202,406

Revenue and Contract Balances

Revenue and Contract Balances	6 Months Ended
	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue and Contract Balances	REVENUE AND CONTRACT BALANCES Disaggregation of Revenue The following table summarizes revenue by geography based on the shipping address of end customers who have contracted to use our platform for the periods presented (in thousands, except percentages): Three Months Ended July 31, 2023 Three Months Ended July 31, 2022 Amount % of Revenue Amount % of Revenue United States $ 95,785 64 % $ 68,392 67 % International 53,636 36 34,113 33 Total $ 149,421 100 % $ 102,505 100 % Six Months Ended July 31, 2023 Six Months Ended July 31, 2022 Amount % of Revenue Amount % of Revenue United States $ 181,456 64 % $ 120,948 67 % International 101,358 36 59,812 33 Total $ 282,814 100 % $ 180,760 100 % No single country other than the United States represented 10% or more of our revenue during the three and six months ended July 31, 2023 and 2022. Substantially all of our sales are fulfilled our through channel partners, including distributors, resellers, managed security service providers, and others. Contract Balances Contract assets consist of unbilled accounts receivable, which arise when a right to consideration for our performance under the customer contract occurs before invoicing the customer. The amount of unbilled accounts receivable included within accounts receivable, net on the condensed consolidated balance sheets was $2.5 million and $1.5 million as of July 31, 2023 and January 31, 2023, respectively. Contract liabilities consist of deferred revenue, which represents invoices billed in advance of performance under a contract. Deferred revenue is recognized as revenue over the contractual period. The deferred revenue balance was $421.4 million and $406.3 million as of July 31, 2023 and January 31, 2023, respectively. We recognized revenue of $92.3 million and $55.4 million during the three months ended July 31, 2023 and 2022, respectively, and $192.6 million and $115.4 million during the six months ended July 31, 2023 and 2022, respectively, that was included in the corresponding contract liability balance at the beginning of the period. Remaining Performance Obligations Our contracts with customers typically range from one As of July 31, 2023, our remaining performance obligations were $676.1 million, of which we expect to recognize 87% as revenue over the next 24 months, with the remainder to be recognized thereafter.

Cash and Cash Equivalents, Inve

Cash and Cash Equivalents, Investments and Fair Value Measurements	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Cash and Cash Equivalents, Investments and Fair Value Measurements	CASH AND CASH EQUIVALENTS, INVESTMENTS, AND FAIR VALUE MEASUREMENTS The following tables summarizes information about our cash, cash equivalents, and investments by investment category as of July 31, 2023 and January 31, 2023 (in thousands): As of July 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash Level 1 $ 36,995 $ — $ — $ 36,995 Money market funds Level 1 75,994 — — 75,994 U.S. Treasury securities Level 1 20,080 — (4) 20,076 Total cash and cash equivalents $ 133,069 $ — $ (4) $ 133,065 Short-term investments: U.S. Treasury securities Level 1 $ 231,728 $ — $ (2,002) $ 229,726 Commercial paper Level 2 74,731 — (80) 74,651 Corporate notes and bonds Level 2 191,737 — (2,060) 189,677 U.S. agency securities Level 2 105,285 1 (809) 104,477 Total short-term investments $ 603,481 $ 1 $ (4,951) $ 598,531 Long-term investments: U.S. Treasury securities Level 1 $ 97,724 $ — $ (1,163) $ 96,561 Corporate notes and bonds Level 2 152,734 — (1,599) 151,135 U.S. agency securities Level 2 150,388 3 (1,709) 148,682 Total long-term investments $ 400,846 $ 3 $ (4,471) $ 396,378 Total assets measured at fair value $ 1,137,396 $ 4 $ (9,426) $ 1,127,974 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): As of January 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash Level 1 $ 35,055 $ — $ — $ 35,055 Money market funds Level 1 102,886 — — 102,886 Total cash and cash equivalents $ 137,941 $ — $ — $ 137,941 Short-term investments: U.S. Treasury securities Level 1 $ 144,392 $ 1 $ (501) $ 143,892 Commercial paper Level 2 230,305 30 (667) 229,668 Corporate notes and bonds Level 2 38,443 15 (148) 38,310 U.S. agency securities Level 2 74,060 3 (349) 73,714 Total short-term investments $ 487,200 $ 49 $ (1,665) $ 485,584 Long-term investments: U.S. Treasury securities Level 1 $ 192,337 $ — $ (2,460) $ 189,877 Corporate notes and bonds Level 2 233,946 178 (2,029) 232,095 U.S. agency securities Level 2 101,844 27 (921) 100,950 Total long-term investments $ 528,127 $ 205 $ (5,410) $ 522,922 Total assets measured at fair value $ 1,153,268 $ 254 $ (7,075) $ 1,146,447 We invest in highly rated securities with a weighted average maturity of 18 months or less. As of July 31, 2023, all of our investments will mature within 2 years. There were no transfers between the levels of the fair value hierarchy during the three and six months ended July 31, 2023 and 2022. As of July 31, 2023, we determined that the declines in the market value of our investment portfolio were not driven by credit related factors. During the three and six months ended July 31, 2023 and 2022, we did not recognize any losses on our investments due to credit related factors. As of July 31, 2023, no unrealized losses were in a continuous unrealized loss position for more than twelve months. The tables above do not include the Company’s strategic investments in non-marketable debt and equity securities, which are classified as level 3 investments and were $13.9 million and $12.5 million as of July 31, 2023 and January 31, 2023, respectively.

Intangible Assets

Intangible Assets	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	INTANGIBLE ASSETS Intangible assets, net consisted of the following (in thousands): As of July 31, As of January 31, 2023 2023 Developed technology $ 78,700 $ 78,700 Customer relationship 79,100 79,100 Backlog 11,100 11,100 Non-compete agreements 650 650 Trademarks 150 150 Patents 1,716 1,501 Total finite-lived intangible assets 171,416 171,201 Less: accumulated amortization (40,544) (26,363) Total finite-lived intangible assets, net $ 130,872 $ 144,838 Indefinite-lived intangible assets - domain names 255 255 Total intangible assets, net $ 131,127 $ 145,093 Amortization expense of intangible assets was $7.2 million and $7.3 million for the three months ended July 31, 2023 and 2022, respectively, and $14.2 million and $8.0 million for the six months ended July 31, 2023 and 2022, respectively. As of July 31, 2023, estimated future amortization expense is as follows (in thousands): Fiscal Year Ending January 31, Remainder of 2024 $ 14,400 2025 24,240 2026 22,807 2027 22,807 2028 13,248 Thereafter 33,370 Total $ 130,872

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	STOCK-BASED COMPENSATION Stock-Based Compensation Expense The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Cost of revenue $ 4,068 $ 2,399 $ 8,241 $ 4,247 Research and development 15,452 13,495 30,242 23,958 Sales and marketing 13,681 9,715 26,277 16,811 General and administrative 20,705 15,392 44,695 27,615 Restructuring (1,060) — (1,060) — Total $ 52,846 $ 41,001 $ 108,395 $ 72,631 Restricted Stock Units A summary of our restricted stock unit (RSU) activity is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2023 14,409,166 $ 27.37 Granted 17,082,796 16.40 Released (2,491,451) 28.34 Forfeited (1,955,209) 22.58 Outstanding as of July 31, 2023 27,045,302 $ 20.70 As of July 31, 2023, we had unrecognized stock-based compensation expense related to unvested RSUs of $497.5 million that is expected to be recognized on a straight-line basis over a weighted-average period of 3.3 years. Stock Options A summary of our stock option activity is as follows: Number of Options Weighted-Average Exercise Price Outstanding as of January 31, 2023 32,446,814 $ 4.71 Exercised (5,074,687) $ 2.73 Forfeited (531,038) $ 5.56 Outstanding as of July 31, 2023 26,841,089 $ 5.07 Expected to vest as of July 31, 2023 26,841,089 $ 5.07 Vested and exercisable as of July 31, 2023 18,151,473 $ 3.91 No stock options were granted during the six months ended July 31, 2023. As of July 31, 2023, we had unrecognized stock-based compensation expense related to unvested options of $75.1 million that is expected to be recognized on a straight-line basis over a weighted-average period of 2.0 years. Milestone Options In March 2021, we granted options to purchase 1,404,605 shares of Class B common stock subject to service-based, performance-based, and market-based vesting conditions to our Chief Executive Officer and Chief Financial Officer under our 2013 Equity Incentive Plan. These stock options will vest 100% upon the occurrence of (a) our initial public offering (IPO) (the performance-based vesting condition), which was completed in June 2021, and (b) the achievement of certain share price targets (the market-based vesting conditions), subject to the executive’s continued service to us from the grant date through the milestone events. As of July 31, 2023, the share price targets have not been achieved, therefore, these stock options remain unvested. For these options, we used a Monte Carlo simulation to determine the fair value at the grant date and the implied service period. During the three and six months ended July 31, 2023, we recorded $0.9 million and $1.8 million, respectively, of stock-based compensation expense related to these milestone options. During the three and six months ended July 31, 2022, we recorded $0.9 million and $1.8 million, respectively, of stock-based compensation expense. As of July 31, 2023, we had unrecognized stock-based compensation expense related to these milestone options of $10.9 million that is expected to be recognized over the remaining implied service period of 3.1 years. Performance Share Units In March and May 2023, we granted Performance Stock Units (PSU) covering 1,133,455 shares of Class A common stock at target to certain executives subject to service-based and performance-based vesting conditions. These PSUs may vest from 0% to 225% of the number of target shares based on the achievement of certain financial performance metrics and will vest over four years from the grant date. As of July 31, 2023, we have reassessed the financial performance metrics for these PSUs and consider achievement to be improbable (0% of target shares to vest). As a result, we have reversed all previously recognized expense. As such, we have not recorded any stock-based compensation expense and have no unrecognized stock-based compensation expense related to these PSUs. Restricted Common Stock In connection with the acquisition of Attivo Networks, Inc. (Attivo), we issued 63,327 shares of restricted Class A common stock to Attivo’s employees. We recorded stock-based compensation expense related to these restricted shares of $0.1 million and $0.4 million, respectively, during the three and six months ended July 31, 2023, respectively. We recorded stock-based compensation expense related to these restricted shares of $0.3 million during each of the three and six months ended July 31, 2022. As of July 31, 2023, we had unrecognized stock-based compensation expense related to this unvested restricted common stock of $0.6 million. In connection with the acquisition of Scalyr, Inc. (Scalyr) in February 2021, we issued 1,315,099 shares of restricted common stock. During the six months ended July 31, 2023 we recorded $0.2 million of stock-based compensation expense related to these restricted shares. No expense was recorded during the three months ended July 31, 2023 related to these restricted shares. During the three and six months ended July 31, 2022, we recorded $2.1 million and $4.2 million, respectively, of stock-based compensation expense. As of July 31, 2023, this restricted common stock had fully vested. Employee Stock Purchase Plan We recognized stock-based compensation expense related to the Employee Stock Purchase Plan (ESPP) of $2.9 million and $5.9 million, re, during the three and six months ended July 31, 2023. We recognized stock-based compensation expense of $3.8 million and $6.5 million, respectively, during the three and six months ended July 31, 2022, respectively. During the three and six months ended July 31, 2023, we recorded $0.1 million and $0.3 million, respectively, in expense related to modification of our ESPP as a result of the decrease in our stock price in July 2022 and January 2023, which triggered resets of the ESPP offering periods in accordance with the terms of the ESPP. During the three and six months ended July 31, 2022, we recorded $0.2 million in stock-based compensation expense. As of July 31, 2023, there is no remaining unrecognized stock-based compensation expense related to modification of our ESPP. Attivo Acquisition In connection with our acquisition of Attivo (Attivo Acquisition), we granted 539,795 shares of RSUs under our 2021 Equity Incentive Plan that will vest over a period of three years contingent on continued employment of certain Attivo employees, for which stock-based compensation expense will be recognized ratably over the vesting period. Attivo Equity Incentive Plan In connection with the Attivo Acquisition, we assumed unvested stock options that were granted under the Attivo 2011 Equity Incentive Plan (Attivo Plan). We do not intend to grant any additional shares under the Attivo Plan and the Attivo Plan will continue to govern the terms and conditions of the outstanding awards previously granted thereunder. Any shares underlying stock options that are expired, canceled, forfeited or repurchased under the Attivo Plan will be automatically available for issuance as Class A common stock pursuant to our 2021 Equity Incentive Plan. Modification During the third quarter of fiscal 2023, certain members of our management team converted to non-employee consultants. The transition has been accounted for as a modification, under which, the exercise period of certain vested awards has been extended and a certain number of unvested awards will vest through the end of the consulting agreements. During the three and six months ended July 31, 2023, we recognized an incremental charge of $2.0 million and $4.0 million, respectively, related to the transition of these employees to non-employee consultants and expect to recognize an aggregate of an additional $2.2 million in expense over the requisite service period through the fourth quarter of 2024.

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES We compute our tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date income from continuing operations and adjusting for discrete items arising in that quarter. We had an effective tax rate of (1.7)% and 8.4% for the three months ended July 31, 2023 and 2022, respectively, and (1.3)% and 4.4% for the six months ended July 31, 2023 and 2022, respectively. We have incurred U.S. operating losses and have profits or offsetting loss carryforwards in certain foreign jurisdictions. In connection with the Attivo Acquisition, we recorded a net deferred tax liability primarily attributable to identifiable acquired intangibles. This net deferred tax liability is considered an additional source of income to support the realizability of the Company's deferred tax asset, and as a result we released a portion of the valuation allowance and recorded a one-time discrete tax benefit of $9.7 million for the three and six months ended July 31, 2022.

Net Loss Per Share Attributable

Net Loss Per Share Attributable To Common Stockholders	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERSBasic and diluted net loss per share attributable to common stockholders is computed in conformity with the two-class method required for participating securities. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive common stock equivalents to the extent they are dilutive. For purposes of this calculation, stock options, restricted common stock, RSUs, PSUs, shares purchased pursuant to our ESPP, and early exercised stock options are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive for all periods presented. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis. Basic and diluted net loss per share attributable to common stockholders was as follows (in thousands, except share and per share data): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Numerator: Net loss attributable to Class A and Class B common stockholders $ (89,538) $ (96,306) $ (196,407) $ (186,140) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 293,170,401 277,417,227 290,775,910 273,424,105 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.31) $ (0.35) $ (0.68) $ (0.68) The following potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive: As of July 31, 2023 2022 Stock options 26,841,089 38,316,073 Shares subject to repurchase 36,452 298,374 RSUs and PSUs 27,045,302 1,343,582 ESPP shares 190,723 109,217 Restricted common stock 22,393 405,620 Contingently issuable shares — 1,317,079 Total 54,135,959 41,789,945

Commitment and Contingencies

Commitment and Contingencies	6 Months Ended
	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Legal Contingencies From time to time, we may be a party to various legal proceedings and subject to claims in the ordinary course of business. Securities Litigation On June 6, 2023, a securities class action was filed against the Company, its Chief Executive Officer and its Chief Financial Officer, in the Northern District of California, captioned Johansson v. SentinelOne, Inc., Case No. 4:23-cv-02786. The suit is brought on behalf of an alleged class of stockholders who purchased or acquired shares of the Company’s Class A common stock between June 1, 2022 and June 1, 2023. The complaint alleges that defendants made false or misleading statements about the Company's business, operations and prospects, including its annual recurring revenues and internal controls, and purports to assert claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended. A substantially similar suit was filed on June 16, 2023 in the same court against the same defendants asserting the same claims, captioned Nyren v. SentinelOne, Inc., Case No. 4:23-cv-02982. Plaintiffs have moved to consolidate the cases. The suits are in their preliminary phase, and no response to the complaints in either action is currently due. The Company believes the cases are without merit and intends to defend the suits vigorously. BlackBerry Litigation Starting in October 2019, BlackBerry Corp. and its subsidiary Cylance, Inc. (BlackBerry) filed a total of nine proceedings (seven lawsuits and two arbitrations) against us and certain former BlackBerry employees who joined our company. In these proceedings, BlackBerry alleges that it has viable legal claims as a result of its former employees joining us. Many of these proceedings have now been dismissed. The status of each of the currently pending proceedings is discussed below. We have defended against these claims vigorously and expect to continue to do so. BlackBerry Corp., et al. v. Coulter, et al. On October 17, 2019, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Chris Coulter, in the Vermont Superior Court—Chittenden Unit, Case No. 953-10-19 Cncv, against Chris Coulter, a now-former employee who worked in our Vigilance services team (the Vermont Action). On October 23, 2019, BlackBerry filed an amended complaint that added the company as a defendant. The amended complaint asserts claims against us for conspiracy, tortious interference with contract, aiding and abetting breach of fiduciary duties, and misappropriation of trade secrets. On April 17, 2020, the court in the Vermont Action issued a preliminary injunction that enjoined Mr. Coulter from working at our company until after February 2021. As a result of the court’s order, Mr. Coulter chose to seek other employment and is no longer employed by us. On January 15, 2021, the court entered an order narrowing the scope of the case and limiting the claims against us to avoid conflict with a similar action that was previously filed in California and was dismissed. The Vermont Action is currently pending. Dispositive motions are currently due by September 15, 2023; no trial date has been set. On October 25, 2019, BlackBerry commenced a separate action captioned BlackBerry Corp., et al v. Coulter, et al., No. 2019-0854-JTL (Del. Ch.) (the Delaware Action) against Mr. Coulter and the Company in Delaware Chancery Court. The court stayed this case pending resolution of the Vermont Action. On February 7, 2020, BlackBerry voluntarily dismissed without prejudice all claims against Mr. Coulter and us in the Delaware Action. On December 3, 2019, BlackBerry initiated a largely duplicative arbitration solely against Mr. Coulter administered by JAMS, an alternative dispute resolution provider. That arbitration, however, was dismissed on or about March 30, 2021, with JAMS informing us that they had closed their files on this matter on April 30, 2021. BlackBerry Corp. et al. v. Sentinel Labs, Inc., et al. On January 16, 2020, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Sentinel Labs, Inc., et al., No. 20CV361950 in the California Superior Court of Santa Clara County, California against us and unnamed “Doe” defendants (who counsel understands are all former BlackBerry employees that we later employed), asserting claims for trade secret misappropriation and unfair business practices (the California Action). We filed counterclaims that, in part, seek to invalidate unlawful provisions under California law in BlackBerry’s agreements it entered into with its employees. Between December 2020 and August 2021, there were several rounds of motion practice, court hearings, and court orders relating to the sufficiency of BlackBerry’s identification of its alleged trade secrets in connection with its misappropriation of trade secrets claim, resulting in a narrowed scope of this claim. In March 2023, BlackBerry filed an amended complaint with an additional claim for unfair business practices. We demurred to that claim, and Blackberry subsequently withdrew it. We continue to vigorously litigate this lawsuit, including our counterclaims against BlackBerry. Fact discovery has now closed, with the exception of certain depositions, and a trial has been set for March 28, 2024. BlackBerry Corp., et al. v. Quinn, et al. On February 17, 2020, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Quinn, et al., Case No. D-1-GN-20-00096, in 459th Judicial District of Travis County, Texas, against Sean Quinn, our now-former employee, and the Company. On August 8, 2020, we and Mr. Quinn moved to stay or dismiss this case in light of the overlapping issues between this lawsuit and the California Action. On September 21, 2020, the court stayed this case pending resolution of the California Action. This lawsuit remains stayed and is pending in abeyance before the Texas court. BlackBerry Corp., et al. v. Kaylan Brown Coulter. On April 7, 2022, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Kaylan Brown Coulter, Case No. 22-cv-01249, in the Superior Court— Chittenden Unit, Vermont, against Kaylan Brown-Coulter, the wife of Chris Coulter (referenced above), alleging breach of non-disclosure and non-solicitation agreements, breach of covenant of good faith and fair dealing, breach of fiduciary duties, and civil conspiracy. While this is part of the same series of lawsuits by BlackBerry, we were not named in this action. On May 6, 2022, Ms. Brown-Coulter removed the case to the United States District Court for the District of Vermont (Case No. 5:22-cv-98). Shortly thereafter, on May 13, 2022, Ms. Brown-Coulter filed a motion to dismiss all claims under Federal Rule of Civil Procedure 12(b)(6). The court granted the motion to dismiss in part, dismissing two of the four counts and ordering further briefing in a third. Discovery (both fact and expert) is currently set to close by October 15, 2023, and the matter is currently set to be trial ready by March 1, 2024 unless a motion for summary judgment is pending. We have not recorded any accruals for loss contingencies associated with these legal proceedings, determined that an unfavorable outcome is probable, or determined that the amount or range of any possible loss is reasonably estimable. We believe that there are no other pending or threatened legal proceedings that are likely to have a material adverse effect on our condensed consolidated financial statements. Warranties and Indemnification Our services are generally warranted to deliver and operate in a manner consistent with general industry standards that are reasonably applicable and materially conform with our documentation under normal use and circumstances. Our contracts generally include certain provisions for indemnifying customers against liabilities if our products or services infringe a third party’s intellectual property rights. We also offer a limited warranty to certain customers, subject to certain conditions, to cover certain costs incurred by the customer in case of a cybersecurity breach. We have entered into an insurance policy to cover our potential liability arising from this limited warranty arrangement. We have not incurred any material costs related to such obligations and have not accrued any liabilities related to such obligations in the condensed consolidated financial statements as of July 31, 2023 and January 31, 2023. In addition, we also indemnify certain of our directors and executive officers against certain liabilities that may arise while they are serving in good faith in their company capacities. We maintain director and officer liability insurance coverage that would generally enable us to recover a portion of any future amounts paid.

Employee Benefit Plan

Employee Benefit Plan	6 Months Ended
	Jul. 31, 2023
Retirement Benefits [Abstract]
Employee Benefit Plan	EMPLOYEE BENEFIT PLAN Our U.S. employees participate in a 401(k) defined contribution plan sponsored by us. Contributions to the plan are discretionary. There were $0.6 million and $0.9 million, respectively, matching contributions for the three months ended July 31, 2023 and 2022, respectively. There were $2.1 million and $1.4 million, matching contributions for the six months ended July 31, 2023 and 2022, respectively. Israeli Severance Pay Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (Section 14), all of our employees in Israel are entitled to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary. These payments release us from any future severance payment obligation with respect to these employees; as such, any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset on our condensed consolidated balance sheets. We recorded severance expenses related to these employees of $0.9 million and $1.0 million, respectively, for the three months ended July 31, 2023 and 2022. We recorded severance expenses related to these employees of $1.8 million and $2.0 million, respectively, for the six months ended July 31, 2023 and 2022.

Restructuring

Restructuring	6 Months Ended
	Jul. 31, 2023
Restructuring Charges [Abstract]
Restructuring	RESTRUCTURINGIn June 2023, we announced a restructuring plan (Plan) as a result of a review of current strategic priorities, resource allocation, and cost reduction intended to reduce operating costs, improve operating margins and continue advancing our ongoing commitment to profitable growth. The Plan includes a reduction of our current workforce by approximately 5%, or approximately 100 full-time employees. We incurred approximately $4.9 million in charges in connection with the Plan in the three months ended July 31, 2023, which consists of $5.3 million in charges related to severance payments and employee benefits, $0.7 million related to inventory write-offs, offset partially by $1.1 million in savings related to the reversal on stock-based compensation expense. Note that the charges related to inventory write-offs are recognized as cost of sales and not restructuring operating expenses in our condensed consolidated financial statements of operations. The actions associated with the Plan are expected to be substantially complete by the end of fiscal 2024, subject to local law and consultation requirements, as well as our business needs. The following table summarizes our restructuring liability that is included in accrued payroll and benefits on the condensed consolidated balance sheet related to the Plan (in thousands): Severance payments and employee benefits Liability as of January 31, 2023 $ — Charges 5,314 Payments (4,454) Non-cash items — Liability as of July 31, 2023 $ 860

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP), and applicable rules and regulations of the Securities and Exchange Commission (SEC), regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023 filed with the SEC on March 29, 2023 (Annual Report). In management’s opinion, the accompanying unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which reflect all normal recurring adjustments necessary to present fairly the results for the interim periods, but are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of SentinelOne and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our condensed consolidated financial statements. There have been no material changes in our use of estimates during the six months ended July 31, 2023, as compared to the use of estimates disclosed in our Annual Report. Significant Accounting Policies There have been no material changes to our significant accounting policies as compared to the significant accounting policies described in our Annual Report.
Segment and Geographic Information	Segment and Geographic InformationWe have a single operating and reportable segment. Our chief operating decision maker (CODM) is our Chief Executive Officer. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and assessing financial performance.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the condensed consolidated statements of cash flows (in thousands): As of July 31, As of January 31, 2023 2023 Cash and cash equivalents $ 133,065 $ 137,941 Restricted cash, current 61,264 61,264 Restricted cash, non-current 3,084 3,201 $ 197,413 $ 202,406
Schedule of Restrictions on Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the condensed consolidated statements of cash flows (in thousands): As of July 31, As of January 31, 2023 2023 Cash and cash equivalents $ 133,065 $ 137,941 Restricted cash, current 61,264 61,264 Restricted cash, non-current 3,084 3,201 $ 197,413 $ 202,406

Revenue and Contract Balances (

Revenue and Contract Balances (Tables)	6 Months Ended
	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Revenue from External Customers by Geographic Areas	The following table summarizes revenue by geography based on the shipping address of end customers who have contracted to use our platform for the periods presented (in thousands, except percentages): Three Months Ended July 31, 2023 Three Months Ended July 31, 2022 Amount % of Revenue Amount % of Revenue United States $ 95,785 64 % $ 68,392 67 % International 53,636 36 34,113 33 Total $ 149,421 100 % $ 102,505 100 % Six Months Ended July 31, 2023 Six Months Ended July 31, 2022 Amount % of Revenue Amount % of Revenue United States $ 181,456 64 % $ 120,948 67 % International 101,358 36 59,812 33 Total $ 282,814 100 % $ 180,760 100 %

Cash and Cash Equivalents, In_2

Cash and Cash Equivalents, Investments and Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	The following tables summarizes information about our cash, cash equivalents, and investments by investment category as of July 31, 2023 and January 31, 2023 (in thousands): As of July 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash Level 1 $ 36,995 $ — $ — $ 36,995 Money market funds Level 1 75,994 — — 75,994 U.S. Treasury securities Level 1 20,080 — (4) 20,076 Total cash and cash equivalents $ 133,069 $ — $ (4) $ 133,065 Short-term investments: U.S. Treasury securities Level 1 $ 231,728 $ — $ (2,002) $ 229,726 Commercial paper Level 2 74,731 — (80) 74,651 Corporate notes and bonds Level 2 191,737 — (2,060) 189,677 U.S. agency securities Level 2 105,285 1 (809) 104,477 Total short-term investments $ 603,481 $ 1 $ (4,951) $ 598,531 Long-term investments: U.S. Treasury securities Level 1 $ 97,724 $ — $ (1,163) $ 96,561 Corporate notes and bonds Level 2 152,734 — (1,599) 151,135 U.S. agency securities Level 2 150,388 3 (1,709) 148,682 Total long-term investments $ 400,846 $ 3 $ (4,471) $ 396,378 Total assets measured at fair value $ 1,137,396 $ 4 $ (9,426) $ 1,127,974 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): As of January 31, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash Level 1 $ 35,055 $ — $ — $ 35,055 Money market funds Level 1 102,886 — — 102,886 Total cash and cash equivalents $ 137,941 $ — $ — $ 137,941 Short-term investments: U.S. Treasury securities Level 1 $ 144,392 $ 1 $ (501) $ 143,892 Commercial paper Level 2 230,305 30 (667) 229,668 Corporate notes and bonds Level 2 38,443 15 (148) 38,310 U.S. agency securities Level 2 74,060 3 (349) 73,714 Total short-term investments $ 487,200 $ 49 $ (1,665) $ 485,584 Long-term investments: U.S. Treasury securities Level 1 $ 192,337 $ — $ (2,460) $ 189,877 Corporate notes and bonds Level 2 233,946 178 (2,029) 232,095 U.S. agency securities Level 2 101,844 27 (921) 100,950 Total long-term investments $ 528,127 $ 205 $ (5,410) $ 522,922 Total assets measured at fair value $ 1,153,268 $ 254 $ (7,075) $ 1,146,447

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): As of July 31, As of January 31, 2023 2023 Developed technology $ 78,700 $ 78,700 Customer relationship 79,100 79,100 Backlog 11,100 11,100 Non-compete agreements 650 650 Trademarks 150 150 Patents 1,716 1,501 Total finite-lived intangible assets 171,416 171,201 Less: accumulated amortization (40,544) (26,363) Total finite-lived intangible assets, net $ 130,872 $ 144,838 Indefinite-lived intangible assets - domain names 255 255 Total intangible assets, net $ 131,127 $ 145,093
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of July 31, 2023, estimated future amortization expense is as follows (in thousands): Fiscal Year Ending January 31, Remainder of 2024 $ 14,400 2025 24,240 2026 22,807 2027 22,807 2028 13,248 Thereafter 33,370 Total $ 130,872

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Components of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Cost of revenue $ 4,068 $ 2,399 $ 8,241 $ 4,247 Research and development 15,452 13,495 30,242 23,958 Sales and marketing 13,681 9,715 26,277 16,811 General and administrative 20,705 15,392 44,695 27,615 Restructuring (1,060) — (1,060) — Total $ 52,846 $ 41,001 $ 108,395 $ 72,631
Schedule of Nonvested Restricted Stock Shares Activity	A summary of our restricted stock unit (RSU) activity is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2023 14,409,166 $ 27.37 Granted 17,082,796 16.40 Released (2,491,451) 28.34 Forfeited (1,955,209) 22.58 Outstanding as of July 31, 2023 27,045,302 $ 20.70
Schedule of Share-based Payment Arrangement, Option, Activity	A summary of our stock option activity is as follows: Number of Options Weighted-Average Exercise Price Outstanding as of January 31, 2023 32,446,814 $ 4.71 Exercised (5,074,687) $ 2.73 Forfeited (531,038) $ 5.56 Outstanding as of July 31, 2023 26,841,089 $ 5.07 Expected to vest as of July 31, 2023 26,841,089 $ 5.07 Vested and exercisable as of July 31, 2023 18,151,473 $ 3.91

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable To Common Stockholders (Tables)	6 Months Ended
	Jul. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Basic and diluted net loss per share attributable to common stockholders was as follows (in thousands, except share and per share data): Three Months Ended July 31, Six Months Ended July 31, 2023 2022 2023 2022 Numerator: Net loss attributable to Class A and Class B common stockholders $ (89,538) $ (96,306) $ (196,407) $ (186,140) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 293,170,401 277,417,227 290,775,910 273,424,105 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.31) $ (0.35) $ (0.68) $ (0.68)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive: As of July 31, 2023 2022 Stock options 26,841,089 38,316,073 Shares subject to repurchase 36,452 298,374 RSUs and PSUs 27,045,302 1,343,582 ESPP shares 190,723 109,217 Restricted common stock 22,393 405,620 Contingently issuable shares — 1,317,079 Total 54,135,959 41,789,945

Restructuring (Tables)

Restructuring (Tables)	6 Months Ended
	Jul. 31, 2023
Restructuring Charges [Abstract]
Restructuring and Related Costs	The following table summarizes our restructuring liability that is included in accrued payroll and benefits on the condensed consolidated balance sheet related to the Plan (in thousands): Severance payments and employee benefits Liability as of January 31, 2023 $ — Charges 5,314 Payments (4,454) Non-cash items — Liability as of July 31, 2023 $ 860

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023	Jul. 31, 2022	Jan. 31, 2022
Accounting Policies [Abstract]
Cash and cash equivalents	$ 133,065	$ 137,941
Restricted cash, current	61,264	61,264
Restricted cash, non-current	3,084	3,201
Cash, cash equivalents, restricted cash and restricted cash equivalents	$ 197,413	$ 202,406	$ 334,348	$ 1,672,051

Revenue and Contract Balances -

Revenue and Contract Balances - Disaggregation of Revenue by Geography (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 149,421	$ 102,505	$ 282,814	$ 180,760
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Revenue	100%	100%	100%	100%
United States
Disaggregation of Revenue [Line Items]
Revenue	$ 95,785	$ 68,392	$ 181,456	$ 120,948
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Revenue	64%	67%	64%	67%
International
Disaggregation of Revenue [Line Items]
Revenue	$ 53,636	$ 34,113	$ 101,358	$ 59,812
International | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Revenue	36%	33%	36%	33%

Revenue and Contract Balances_2

Revenue and Contract Balances - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2023
Disaggregation of Revenue [Line Items]
Unbilled receivables, current	$ 2.5		$ 2.5		$ 1.5
Contract with customer, liability	421.4		421.4		$ 406.3
Contract with customer, liability, revenue recognized	92.3	$ 55.4	192.6	$ 115.4
Revenue, remaining performance obligation, amount	$ 676.1		$ 676.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-08-01
Disaggregation of Revenue [Line Items]
Revenue, remaining performance obligation, percentage	87%		87%
Revenue, remaining performance obligation, expected timing of satisfaction, period	24 months		24 months
Minimum
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, contract term			1 year
Maximum
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, contract term			3 years

Cash and Cash Equivalents, In_3

Cash and Cash Equivalents, Investments and Fair Value Measurements - Schedule of Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Cash and cash equivalents:
Amortized Cost	$ 133,065	$ 137,941
Short-term investments:
Amortized Cost	603,481	487,200
Gross Unrealized Gains	1	49
Gross Unrealized Losses	(4,951)	(1,665)
Estimated Fair Value	598,531	485,584
Long-term investments:
Amortized Cost	400,846	528,127
Gross Unrealized Gains	3	205
Gross Unrealized Losses	(4,471)	(5,410)
Estimated Fair Value	396,378	522,922
Total assets measured at fair value, Amortized Cost	1,137,396	1,153,268
Total assets measured at fair value, Gross Unrealized Gains	4	254
Total assets measured at fair value, Gross Unrealized Losses	(9,426)	(7,075)
Total assets measured at fair value, Estimated Fair Value	1,127,974	1,146,447
Cash
Cash and cash equivalents:
Amortized Cost	36,995	35,055
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	36,995	35,055
Total cash and cash equivalents
Cash and cash equivalents:
Amortized Cost	133,069	137,941
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(4)	0
Estimated Fair Value	133,065	137,941
Level 1 | U.S. Treasury securities
Short-term investments:
Amortized Cost	231,728	144,392
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(2,002)	(501)
Estimated Fair Value	229,726	143,892
Long-term investments:
Amortized Cost	97,724	192,337
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1,163)	(2,460)
Estimated Fair Value	96,561	189,877
Level 1 | Money market funds
Cash and cash equivalents:
Amortized Cost	75,994	102,886
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	75,994	102,886
Level 1 | U.S. Treasury securities
Cash and cash equivalents:
Amortized Cost	20,080
Gross Unrealized Gains	0
Gross Unrealized Losses	(4)
Estimated Fair Value	20,076
Level 1 | Commercial paper
Short-term investments:
Amortized Cost	74,731	230,305
Gross Unrealized Gains	0	30
Gross Unrealized Losses	(80)	(667)
Estimated Fair Value	74,651	229,668
Level 1 | Corporate notes and bonds
Short-term investments:
Amortized Cost	191,737	38,443
Gross Unrealized Gains	0	15
Gross Unrealized Losses	(2,060)	(148)
Estimated Fair Value	189,677	38,310
Long-term investments:
Amortized Cost	152,734	233,946
Gross Unrealized Gains	0	178
Gross Unrealized Losses	(1,599)	(2,029)
Estimated Fair Value	151,135	232,095
Level 1 | U.S. agency securities
Short-term investments:
Amortized Cost	105,285	74,060
Gross Unrealized Gains	1	3
Gross Unrealized Losses	(809)	(349)
Estimated Fair Value	104,477	73,714
Long-term investments:
Amortized Cost	150,388	101,844
Gross Unrealized Gains	3	27
Gross Unrealized Losses	(1,709)	(921)
Estimated Fair Value	$ 148,682	$ 100,950

Cash and Cash Equivalents, In_4

Cash and Cash Equivalents, Investments and Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2023	Jan. 31, 2023
Fair Value Assets and Liabilities Measure On Recurring And Nonrecurring Basis [Line Items]
Investments, weighted average maturity		18 months
Investments, term	2 years
Debt and equity securities	$ 400,846	$ 400,846	$ 528,127
Level 3 | Strategic Investments
Fair Value Assets and Liabilities Measure On Recurring And Nonrecurring Basis [Line Items]
Debt and equity securities	$ 13,900	$ 13,900	$ 12,500

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	$ 171,416	$ 171,201
Less: accumulated amortization	(40,544)	(26,363)
Total finite-lived intangible assets, net	130,872	144,838
Indefinite-lived intangible assets - domain names	255	255
Intangible assets, net	131,127	145,093
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	78,700	78,700
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	79,100	79,100
Backlog
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	11,100	11,100
Non-compete agreements
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	650	650
Trademarks
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	150	150
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	$ 1,716	$ 1,501

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 7.2	$ 7.3	$ 14.2	$ 8

Intangible Assets - Amortizatio

Intangible Assets - Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 14,400
2025	24,240
2026	22,807
2027	22,807
2028	13,248
Thereafter	33,370
Total finite-lived intangible assets, net	$ 130,872	$ 144,838

Stock-Based Compensation - Comp

Stock-Based Compensation - Components of Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 52,846	$ 41,001	$ 72,631	$ 108,395
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	4,068	2,399	4,247	8,241
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	15,452	13,495	23,958	30,242
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	13,681	9,715	16,811	26,277
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	20,705	15,392	27,615	44,695
Restructuring
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ (1,060)	$ 0	$ 0	$ (1,060)

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units (Details) - Restricted Stock Units (RSUs)	6 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Outstanding, beginning of period (in shares) | shares	14,409,166
Granted (in shares) | shares	17,082,796
Released (in shares) | shares	(2,491,451)
Forfeited (in shares) | shares	(1,955,209)
Outstanding, end of period (in shares) | shares	27,045,302
Weighted-Average Grant Date Fair Value
Outstanding, beginning of period (in USD per share) | $ / shares	$ 27.37
Granted (in USD per share) | $ / shares	16.40
Released (in USD per share) | $ / shares	28.34
Forfeited (in USD per share) | $ / shares	22.58
Outstanding, end of period (in USD per share) | $ / shares	$ 20.70

Stock-Based Compensation - Re_2

Stock-Based Compensation - Restricted Stock Units and Stock Options Narrative (Details) $ in Millions	6 Months Ended
	Jul. 31, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized, options, amount	$ 75.1
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized amount	$ 497.5
Cost not yet recognized, period for recognition	3 years 3 months 18 days
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized, period for recognition	2 years

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Options (Details) - Stock options - $ / shares	6 Months Ended
	Jul. 31, 2023
Number of Options
Outstanding, beginning of period (in shares)	32,446,814
Exercised (in shares)	(5,074,687)
Forfeited (in shares)	(531,038)
Outstanding, end of period (in shares)	26,841,089
Expected to vest (in shares)	26,841,089
Vested and exercisable, Number (in shares)	18,151,473
Weighted-Average Exercise Price
Outstanding, beginning of period (in USD per share)	$ 4.71
Exercised (in USD per share)	2.73
Forfeited (in USD per share)	5.56
Outstanding, end of period (in USD per share)	5.07
Expected to vest (in USD per shares)	5.07
Vested and exercisable, Weighted average (in USD per share)	$ 3.91

Stock-Based Compensation - Mile

Stock-Based Compensation - Milestone Options Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2021	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense		$ 52,846	$ 41,001	$ 72,631	$ 108,395
Milestone Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	1,404,605
Vesting percentage	100%
Share-based payment arrangement, expense		900	$ 900	1,800	$ 1,800
Cost not yet recognized, amount		$ 10,900		$ 10,900
Cost not yet recognized, period for recognition				3 years 1 month 6 days

Stock-Based Compensation - Perf

Stock-Based Compensation - Performance Share Units Narrative (Details) - Performance share units - shares		3 Months Ended
	Jul. 31, 2023	May 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		1,133,455
Vesting percentage	0%
Award vesting period		4 years
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		0%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		225%

Stock-Based Compensation - Re_3

Stock-Based Compensation - Restricted Common Stock Narrative (Details) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended
	May 03, 2022	Feb. 28, 2021	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense			$ 52,846,000	$ 41,001,000	$ 72,631,000	$ 108,395,000
Restricted common stock | Attivo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)	63,327
Share-based payment arrangement, expense			100,000	300,000	400,000	300,000
Cost not yet recognized amount			600,000		600,000
Restricted common stock | Scalyr
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)		1,315,099
Share-based payment arrangement, expense			$ 0	$ 2,100,000	$ 200,000	$ 4,200,000

Stock-Based Compensation - Empl

Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($)	3 Months Ended		6 Months Ended		18 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense	$ 52,846,000	$ 41,001,000	$ 72,631,000	$ 108,395,000
Share-based payment arrangement, plan modification, incremental cost	2,000,000		4,000,000
Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, plan modification, incremental cost					$ 2,200,000
ESPP shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense	2,900,000	3,800,000	5,900,000	6,500,000
Share-based payment arrangement, plan modification, incremental cost	100,000	$ 200,000	300,000	$ 200,000
Cost not yet recognized amount	$ 0		$ 0

Stock-Based Compensation - Atti

Stock-Based Compensation - Attivo Acquisition Narrative (Details) - Restricted Stock Units (RSUs)	6 Months Ended
	Jul. 31, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	17,082,796
Attivo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	539,795
Award vesting period	3 years

Stock-Based Compensation - Modi

Stock-Based Compensation - Modification Narrative (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended	18 Months Ended
	Jul. 31, 2023	Jul. 31, 2023	Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, plan modification, incremental cost	$ 2	$ 4
Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, plan modification, incremental cost			$ 2.2

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation, percent	(1.70%)	8.40%	(1.30%)	4.40%
Discrete tax benefit		$ 9.7		$ 9.7

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable To Common Stockholders - Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Numerator:
Net loss	$ (89,538)	$ (96,306)	$ (196,407)	$ (186,140)
Denominator:
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	293,170,401	277,417,227	290,775,910	273,424,105
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	293,170,401	277,417,227	290,775,910	273,424,105
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share)	$ (0.31)	$ (0.35)	$ (0.68)	$ (0.68)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share)	$ (0.31)	$ (0.35)	$ (0.68)	$ (0.68)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable To Common Stockholders - Anti-dilutive Securities Excluded from the Diluted Calculation (Details) - shares	6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	54,135,959	41,789,945
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	26,841,089	38,316,073
Shares subject to repurchase
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	36,452	298,374
RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	27,045,302	1,343,582
ESPP shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	190,723	109,217
Restricted common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	22,393	405,620
Contingently issuable shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	1,317,079

Commitment and Contingencies (D

Commitment and Contingencies (Details) - BlackBerry Litigation	1 Months Ended
	Oct. 31, 2019 arbitration claim lawsuit
Loss Contingencies [Line Items]
Loss contingency, new claims filed, number | claim	9
Loss contingency, number of lawsuits | lawsuit	7
Loss contingency, number of arbitrations | arbitration	2

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Restructuring Cost and Reserve [Line Items]
Defined contribution plan, cost	$ 0.6	$ 0.9	$ 2.1	$ 1.4
ISRAEL
Restructuring Cost and Reserve [Line Items]
Severance costs	$ 0.9	$ 1	$ 1.8	$ 2

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended		8 Months Ended
	Jun. 30, 2023 employee	Jul. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)	Jul. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)	Jan. 31, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected number of positions eliminated | employee	100
Restructuring charges, including writeoffs		$ 4,900
Charges		4,255	$ 0	$ 4,255	$ 0
Severance payments and employee benefits
Restructuring Cost and Reserve [Line Items]
Charges		5,300		$ 5,314
Inventory Write-offs
Restructuring Cost and Reserve [Line Items]
Charges		700
Stock-Based Compensation
Restructuring Cost and Reserve [Line Items]
Charges		$ (1,100)
Forecast
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, number of positions eliminated, period percent						5%

Restructuring - Summary of Rest

Restructuring - Summary of Restructuring Liability (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Restructuring Reserve [Roll Forward]
Charges	$ 4,255	$ 0	$ 4,255	$ 0
Severance payments and employee benefits
Restructuring Reserve [Roll Forward]
Liability as of January 31, 2023			0
Charges	5,300		5,314
Payments			(4,454)
Non-cash items			0
Liability as of July 31, 2023	$ 860		$ 860